Unravelling The Mechanism Of MHC Class-I Associated Drug Hypersensitivities
Funder
National Health and Medical Research Council
Funding Amount
$566,308.00
Summary
Some drugs cause adverse reactions that are life threatening. We think these reactions are mediated by killer T cells as they are genetically controlled by immune response genes that normally guide immunity to microbes. We will study immune reactions to the drug abacavir, used to treat HIV (AIDS); allopurinol used to prevent gout and carbamazepine, used to treat epilepsy. The study may also help devise better treatments for patients who experience severe forms of these reactions.
Trustworthy positioning for intelligent transport systems. This project aims to develop a holistic approach for reliable positioning for Intelligent Transport Systems (ITS). This project will address the challenges of integrity monitoring in ITS when using satellite-based technology, its integration with other sensors, and when supported by the proposed Australia National Positioning Infrastructure. It will consider Australian geography, large area, and sparse population, and emphasise rural tra ....Trustworthy positioning for intelligent transport systems. This project aims to develop a holistic approach for reliable positioning for Intelligent Transport Systems (ITS). This project will address the challenges of integrity monitoring in ITS when using satellite-based technology, its integration with other sensors, and when supported by the proposed Australia National Positioning Infrastructure. It will consider Australian geography, large area, and sparse population, and emphasise rural transport. Expected primary outputs include algorithms, a detailed analysis of required systems and recommendations that will help prepare Australia for the importation of self-driving vehicles.Read moreRead less
Towards A National Sports Safety Strategy - Addressing Facilitators And Barriers Towards Safety Guideline Uptake.
Funder
National Health and Medical Research Council
Funding Amount
$965,834.00
Summary
Most sports injury prevention evidence is yet to be translated from professional to community sports settings. Using community-based Australian football clubs, this project will develop and evaluate the strategic implementation of an evidence-based sports safety package. This will provide important information about how to best support community sports clubs to ensure evidence-based safety programs are translated into sustainable policies and practice and public health benefits are maximised
How leaders integrate safety goals for employees to build adaptive safety capabilities in organisations. How can organisations maintain high levels of safety while adapting to constant technological, social, and economic change? This project will investigate how leaders align complex individual goals to develop adaptive safety capability: the capacity of organisations to successfully modify safety systems in the midst of change.
Optimisation Of Antimicrobial Therapy For Severe Bacterial Infections In Neonates And Young Children In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$943,865.00
Summary
This study aims to provide important information on the way young Papua New Guinean children with serious bacterial infections handle antibiotics, including newer agents that may be required if bacterial resistance is confirmed or increases. The data will be used to optimise treatment, thus reducing mortality and potential adverse drug effects, in PNG nad other tropical countries, and may have implications for the developed world as well.
Molecular Pharmacology Of Chemokine Receptor Signalling In Cancer
Funder
National Health and Medical Research Council
Funding Amount
$371,770.00
Summary
Molecular pharmacology is the study of how hormones, neurotransmitters and pharmaceuticals interact with our cells through receptors, which transfer a signal across the cell membrane to change the function of that cell. Chemokine receptors are recognised to play a role in the development of many cancers. Understanding how these receptors work has enormous implications for improving our ability to develop better anti-cancer treatments with fewer side effects.
DYRK1A As A Novel Target For Glioblastoma Therapies
Funder
National Health and Medical Research Council
Funding Amount
$620,294.00
Summary
Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called DYRK1A (using ‘DYRK1A inhibitors’) kills glioblastoma cells. This therapeutic advantage is even greater when combined with drugs approved for other cancers. This project will develop new DYRK1A inhibitors and examine a novel combination treatment for glioblastoma patients. This could initiate a novel therapy that could significantly extend patients’ lives.
Stimulation of the mammalian reproductive system by olfactory pathways. This project answers fundamental questions about mammalian reproductive biology but, because we work with the sheep model, our findings can be applied to two of Australia's biggest export industries, wool and sheepmeat. Understanding the reproductive responses of our production animals to exteroceptive factors such as socio-sexual signals, photoperiod and nutrition is an important first step towards refining the management ....Stimulation of the mammalian reproductive system by olfactory pathways. This project answers fundamental questions about mammalian reproductive biology but, because we work with the sheep model, our findings can be applied to two of Australia's biggest export industries, wool and sheepmeat. Understanding the reproductive responses of our production animals to exteroceptive factors such as socio-sexual signals, photoperiod and nutrition is an important first step towards refining the management of breeding programs. It has been argued that this approach will also minimise, and perhaps even remove the need for, exogenous hormones and drugs for controlling the reproductive process.Read moreRead less
Impact Of An Ivermectin Mass Drug Administration Program Against Endemic Scabies And Strongyloidiasis
Funder
National Health and Medical Research Council
Funding Amount
$1,289,786.00
Summary
Overseas studies suggest sustainable and long term benefits can be obtained through the use of ivermectin in mass drug administration programs to control parasitic infections. Our study will be a critical first step in establishing if such a program can be successful in a remote Indigenous community setting, where the disease burden from scabies and strongyloidiasis (threadworm infections) is very high.
Preclinical Development Of A Therapeutic Anticancer Antibody To C-Met
Funder
National Health and Medical Research Council
Funding Amount
$435,530.00
Summary
Many common cancers cannot be effectively treated. A range of these cancers (e.g. gastric and lung cancer) display the molecule c-Met on their cell surface. c-Met promotes tumour growth; therefore, blocking c-Met is a promising strategy for treating these cancers. However, no antibodies or drugs that target c-Met have been licensed. The therapeutics that are being developed to target c-Met all have considerable limitations. Thus, there is an opportunity to develop a 'best-in-class' therapeutic.